BNGO vs DXCM · rev $14.9M vs P/E 63, rev $2.50B
Bionano Genomics Inc (BNGO) versus DexCom Inc (DXCM) — a side-by-side from cached financials, not a winner call.
Bionano Genomics Inc (BNGO) is a medical instruments & supplies company listed on US.
DexCom Inc (DXCM) is a medical devices company listed on US.
Latest reported BNGO revenue for 2026-06-30 was $14.9M. Net income was -$15.7M. BNGO currently screens at market cap $13.4M.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
BNGO currently screens at market cap $13.4M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Not investment advice. Open the BNGO and DXCM stock pages for the full models.
Not investment advice.